Article
Celecoxib added to risperidone for depressive symptoms in first-episode and drug naïve schizophrenia: Pharmacogenetic impact of BDNF gene polymorphisms
2022-06-01
Abstract excerpt
<title>Abstract</title> <p>Although depressive symptoms are common in patients with schizophrenia (SCZ), depression is not successfully treated in most SCZ patients. SCZ Patients with comorbid depression may have activated inflammatory responses, and celecoxib, a COX2 inhibitor, can dampen inflammation and improve treatment of depression. BDNF may be associated with the treatment response to antidepressants and h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 831a69fe-7c63-5657-906c-8e650c2de415
- DOI
- 10.21203/rs.3.rs-1700453/v1
